Apogee Therapeutics Statistics

Total Valuation

APGE has a market cap or net worth of $2.53 billion. The enterprise value is $1.86 billion.

Market Cap	2.53B
Enterprise Value	1.86B

Important Dates

The next estimated earnings date is Monday, August 11, 2025, before market open.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

APGE has 58.37 million shares outstanding. The number of shares has increased by 57.55% in one year.

Current Share Class	44.88M
Shares Outstanding	58.37M
Shares Change (YoY)	+57.55%
Shares Change (QoQ)	+1.65%
Owned by Insiders (%)	2.12%
Owned by Institutions (%)	92.57%
Float	37.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.57
P/TBV Ratio	3.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.82, with a Debt / Equity ratio of 0.02.

Current Ratio	15.82
Quick Ratio	15.73
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -27.85% and return on invested capital (ROIC) is -20.31%.

Return on Equity (ROE)	-27.85%
Return on Assets (ROA)	-19.65%
Return on Invested Capital (ROIC)	-20.31%
Return on Capital Employed (ROCE)	-35.49%
Revenue Per Employee	n/a
Profits Per Employee	-$1.05M
Employee Count	196
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, APGE has paid $101,000 in taxes.

Income Tax	101,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.41% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+13.41%
50-Day Moving Average	39.07
200-Day Moving Average	43.58
Relative Strength Index (RSI)	59.04
Average Volume (20 Days)	871,996

Short Selling Information

The latest short interest is 9.18 million, so 15.72% of the outstanding shares have been sold short.

Short Interest	9.18M
Short Previous Month	10.15M
Short % of Shares Out	15.72%
Short % of Float	24.41%
Short Ratio (days to cover)	12.41

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-241.79M
Pretax Income	-103.55M
Net Income	-205.39M
EBITDA	-241.42M
EBIT	-241.79M
Earnings Per Share (EPS)	-$3.59

Full Income Statement

Balance Sheet

The company has $513.33 million in cash and $11.82 million in debt, giving a net cash position of $669.62 million or $11.47 per share.

Cash & Cash Equivalents	513.33M
Total Debt	11.82M
Net Cash	669.62M
Net Cash Per Share	$11.47
Equity (Book Value)	673.36M
Book Value Per Share	11.55
Working Capital	488.57M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$188.02 million and capital expenditures -$5.12 million, giving a free cash flow of -$193.13 million.

Operating Cash Flow	-188.02M
Capital Expenditures	-5.12M
Free Cash Flow	-193.13M
FCF Per Share	-$3.31

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APGE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-57.55%
Shareholder Yield	-57.55%
Earnings Yield	-8.11%
FCF Yield	-7.63%

Analyst Forecast

The average price target for APGE is $91.33, which is 110.54% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$91.33
Price Target Difference	110.54%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	8.94%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1